化学療法に伴う 好中球減少症:世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chemotherapy Induced Neutropenia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chemotherapy Induced Neutropenia to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chemotherapy Induced Neutropenia to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Chemotherapy Induced Neutropenia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Chemotherapy Induced Neutropenia Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Chemotherapy Induced Neutropenia 32
Apr 08, 2013: Spectrum Pharma Initiates Phase II Study Of Long-acting GCSF Drug Candidate SPI-2012 For Treatment Of Chemotherapy-induced Neutropenia 32
Jan 07, 2013: Generon Initiates Phase I/II Clinical Trial Of F-627 For Treatment Of Breast Cancer In China 32
May 31, 2011: Teva To Present Phase II Data Of Granulocyte Colony Stimulating Factor XM22 At ASCO 32
Mar 22, 2011: Cellerant Initiates Phase I/II Clinical Trial Of CLT-008 For Chemotherapy Induced Neutropenia In Acute Leukemia Patients 33
Nov 22, 2010: Generon Completes Dosing In Phase I Study Of F-627 In Australia 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Teva Pharmaceutical Industries Limited 34
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 34
Kirin Holdings Company, Limited 35
Clinical Trial Overview of Kirin Holdings Company, Limited 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Dong-A Socio Holdings Co Ltd 37
Clinical Trial Overview of Dong-A Socio Holdings Co Ltd 37
Amgen Inc. 38
Clinical Trial Overview of Amgen Inc. 38
Sanofi 39
Clinical Trial Overview of Sanofi 39
Lupin Limited 40
Clinical Trial Overview of Lupin Limited 40
Takeda Pharmaceutical Company Limited 41
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 41
Hospira, Inc. 42
Clinical Trial Overview of Hospira, Inc. 42
Hangzhou Jiuyuan Gene Engineering Co. Ltd 43
Clinical Trial Overview of Hangzhou Jiuyuan Gene Engineering Co. Ltd 43
Clinical Trial Overview of Top Institutes / Government 44
Jules Bordet Institute 44
Clinical Trial Overview of Jules Bordet Institute 44
Istituto Giannina Gaslini 45
Clinical Trial Overview of Istituto Giannina Gaslini 45
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 46
Clinical Trial Overview of Cancer Institute and Hospital, Chinese Academy of Medical Sciences 46
Tri-Service General Hospital 47
Clinical Trial Overview of Tri-Service General Hospital 47
Terry Fox Foundation 48
Clinical Trial Overview of Terry Fox Foundation 48
Peter MacCallum Cancer Centre 49
Clinical Trial Overview of Peter MacCallum Cancer Centre 49
Capital Medical University 50
Clinical Trial Overview of Capital Medical University 50
University of Bern 51
Clinical Trial Overview of University of Bern 51
Asan Medical Center 52
Clinical Trial Overview of Asan Medical Center 52
Hadassah Medical Organization 53
Clinical Trial Overview of Hadassah Medical Organization 53
Five Key Clinical Profiles 54
Appendix 91
Abbreviations 91
Definitions 91
Research Methodology 92
Secondary Research 92
About GlobalData 93
Contact Us 93
Disclaimer 93
Source 94


【レポート販売概要】

■ タイトル:化学療法に伴う 好中球減少症:世界の臨床試験レビュー(2014年上半期)
■ 英文:Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2014
■ 発行日:2014年3月19日
■ 調査会社:GlobalData
■ 商品コード:GDHC2034CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。